Evidence map›Paper›PMID 30424737›Full record

ArticleBMC infectious diseases2018

Study protocol of the iMPaCT project: a longitudinal cohort study assessing psychological determinants, sexual behaviour and chlamydia (re)infections in heterosexual STI clinic visitors.

Daphne A van Wees, Janneke C M Heijne, Titia Heijman, Karlijn C J G Kampman, Karin Westra, Anne de Vries, Mirjam E E Kretzschmar, Chantal den Daas

Abstract read
In one paragraph

Article in BMC infectious diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Daphne A van WeesCentre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands. daphne.van.wees@rivm.nl.ORCID http://orcid.org/0000-0002-6562-7029
Janneke C M HeijneCentre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Titia HeijmanPublic Health Service Amsterdam, Amsterdam, The Netherlands.
Karlijn C J G KampmanPublic Health Service Twente, Enschede, The Netherlands.
Karin WestraPublic Health Service Hollands Noorden, Alkmaar, The Netherlands.
Anne de VriesPublic Health Service Kennemerland, Haarlem, The Netherlands.
Mirjam E E KretzschmarCentre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Chantal den DaasCentre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.

Funding

Strategic Programme (SPR) of the National Institute for Public Health and the Environment (RIVM) S/113004/01/IP
6 · The paper itself

Abstract

backgroundChlamydia trachomatis (chlamydia), the most commonly reported sexually transmitted infection (STI) in the Netherlands, can lead to severe reproductive complications. Reasons for the sustained chlamydia prevalence in young individuals, even in countries with chlamydia screening programs, might be the asymptomatic nature of chlamydia infections, and high reinfection rates after treatment. When individuals are unaware of their infection, preventive behaviour or health-care seeking behaviour mostly depends on psychological determinants, such as risk perception. Furthermore, behaviour change after a diagnosis might be vital to reduce reinfection rates. This makes the incorporation of psychological determinants and behaviour change in mathematical models estimating the impact of interventions on chlamydia transmission especially important. Therefore, quantitative real-life data to inform these models is needed.

methodsA longitudinal cohort study will be conducted to explore the link between psychological and behavioural determinants and chlamydia (re)infection among heterosexual STI clinic visitors aged 18-24 years. Participants will be recruited at the STI clinics of the public health services of Amsterdam, Hollands Noorden, Kennemerland, and Twente. Participants are enrolled for a year, and questionnaires are administrated at four time points: baseline (before an STI consultation), three-week, six-month and at one-year follow-up. To be able to link psychological and behavioural determinants to (re)infections, participants will be tested for chlamydia at enrolment and at six-month follow-up. Data from the longitudinal cohort study will be used to develop mathematical models for curable STI incorporating these determinants to be able to better estimate the impact of interventions. DISCUSSION: This study will provide insights into the link between psychological and behavioural determinants, including short-term and long-term changes after diagnosis, and chlamydia (re)infections. Our mathematical model, informed by data from the longitudinal cohort study, will be able to estimate the impact of interventions on chlamydia prevalence, and identify and prioritise successful interventions for the future. These interventions could be implemented at STI clinics tailored to psychological and behavioural characteristics of individuals.

trial registrationDutch Trial Register NTR-6307 . Retrospectively registered 11-nov-2016.

Indexed as

HeterosexualityAdolescentAdultAmbulatory Care FacilitiesChlamydia InfectionsChlamydia trachomatisCohort StudiesFemaleHumansLongitudinal StudiesMaleNetherlandsPrevalenceRecurrenceRetrospective StudiesRisk FactorsBehaviour changeChlamydia trachomatisMathematical modelPsychological determinantsReinfectionSexual behaviourSexually transmitted diseasesSTI clinic

Identifiers

PMID30424737
PMCPMC6234675

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.